Novavax COVID-19 Vaccine Phase 3 Trial To Begin In U.S.

Maryland-based Novavax announced Monday it would be its phase 3 trial for its COVID-19 vaccine in the U.S. and Mexico. Its the fifth company to begin a large-scale trial of the coronavirus vaccine in the U.S.